Kimmel & ABC, Nvidia’s OpenAI Investment, and Tylenol’s Trump Problem
Kimmel & ABC, Nvidia’s OpenAI Investment, and Tylenol’s Trump Problem
225 days agoPivotNew York Magazine
Podcast50 min 27 sec
Listen to Episode
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Investors should be cautious of NVIDIA (NVDA), as its recent deal with OpenAI is viewed as a "late-stage bubble" signal and a form of financial engineering that could be artificially inflating its revenue. This powerful partnership, described as "Wintel times 10," also creates significant anti-trust risk that could negatively impact the stock. A potential contrarian opportunity may exist in Kenview (KVUE), the maker of Tylenol, which has seen its stock fall over 7% due to recent negative publicity. A strong crisis management response from the company to defend its brand could lead to a significant stock recovery for investors. As a general strategy, be highly skeptical of future mega-mergers and ensure your portfolio is well-diversified, as market gains are dangerously concentrated in just a few stocks.

Detailed Analysis

NVIDIA (NVDA) & OpenAI

  • NVIDIA is investing $100 billion in OpenAI. In return, OpenAI will use that money to purchase NVIDIA's AI semiconductors (chips) for its data centers.
  • The hosts described this deal as a "round trip" and a "shell game," expressing significant skepticism.
  • Scott Galloway compared the situation to the dot-com bubble of the late 90s, specifically mentioning AOL, calling it a "late stage bubble" signal.
    • The concern is that this is financial engineering. NVIDIA issues new stock (a 2.5% dilution for existing shareholders) to fund OpenAI, which then becomes revenue for NVIDIA.
    • This can boost NVIDIA's stock price in the short term by more than the cost of the dilution, but it's not organic growth. Galloway referred to it as "kind of a pyramid scheme."
  • A major risk highlighted is the creation of an anti-competitive partnership.
    • NVIDIA has over 90% of the market for AI computing chips, and OpenAI has 77% of the market for front-end Large Language Models (LLMs).
    • The concern is that they will coordinate, designing chips specifically for OpenAI's models and giving OpenAI early access, which could stifle competition from other AI companies. This was described as "Wintel times 10," referring to the historic dominance of Microsoft Windows and Intel chips in the PC market.

Takeaways

  • Be cautious of the valuation. The structure of this deal is seen as a red flag that could be artificially inflating NVIDIA's revenue and, by extension, its stock price. It's a sign that we might be in the later stages of a market bubble, particularly in the AI sector.
  • Monitor for regulatory risk. The deal creates a powerful partnership that could attract scrutiny from antitrust regulators in the future. Any action from regulators could negatively impact both companies.
  • Understand the competitive landscape. The hosts noted that all major AI models are "converging" and becoming very similar. This suggests that having a sustainable, long-term technical advantage may be difficult for any single company, including OpenAI.

Kenview (KVUE)

  • Kenview is the company that makes Tylenol. Its stock was down 7% in the five days leading up to the podcast taping.
  • The drop was attributed to claims by former President Trump linking Tylenol to autism, which has created a significant public relations and business challenge for the company. Tylenol is a major product, generating an estimated $1 billion in annual sales.
  • The hosts discussed that the company should "go on the offensive" against what they consider misinformation, drawing parallels to the famous Johnson & Johnson (J&J) Tylenol crisis management case in the 1980s.
    • In that historical case, J&J's aggressive and transparent response (pulling all products from shelves after a tampering incident) ultimately built enormous trust and is considered the gold standard for crisis management.
  • The current situation is different because the company has done nothing wrong, but the advice remains the same: be aggressive in defending the product's reputation to protect its market value. The company has reportedly lost 10% of its market cap over the issue.

Takeaways

  • Brand reputation is a key risk. This situation shows how quickly a company's value can be impacted by external claims, even if they are unsubstantiated. For a consumer-facing company like Kenview, the Tylenol brand is one of its most valuable assets.
  • Watch the company's response. Investors should monitor how Kenview's management handles this crisis. A strong, proactive response could help the stock recover, while a passive approach might allow the negative sentiment to harm sales and the stock price further.

Investment Theme: Late-Stage Bubble & M&A Activity

  • A prediction was made that the market is heading for a massive, "Time Warner-like" acquisition that will ultimately be seen as a disaster.
  • The reasoning is that market gains are highly concentrated. Since 2021, just 10 companies have driven 55% of the gains in the S&P 500.
  • These mega-cap companies have extremely high valuations, which the host compared to having a "preloaded credit card" with trillions of dollars that they feel pressured to spend before their valuations come back to earth.
  • This pressure is expected to lead to a wave of huge, potentially reckless, mergers and acquisitions (M&A). The NVIDIA-OpenAI deal is viewed as an early example of this trend of "promiscuous" and "weird" deal-making.

Takeaways

  • Be wary of mega-mergers. Investors should be highly skeptical of massive M&A deals announced in this environment. History is filled with large, headline-grabbing mergers that ultimately destroyed shareholder value.
  • Diversification is key. The high concentration of market returns in just a few stocks is a significant risk. This is a good reminder for investors to ensure their portfolios are well-diversified and not overly exposed to a handful of high-flying tech names.

Investment Theme: Broader Economic Health

  • The hosts warned that major stock indices like the NASDAQ and the Dow Jones may be giving a false impression of the economy's health.
  • While the stock market is performing well (driven by a few large companies), there are signs of stress for the average consumer, or the "main street economy."
  • Negative economic indicators mentioned include:
    • Rising sales of Hamburger Helper (a sign consumers are cutting back on spending).
    • Booming business for pawn shops.
    • A significant increase in people surrendering their pets to shelters, suggesting financial distress.

Takeaways

  • Look beyond the headlines. Investors should consider a wider range of economic data beyond just the major stock indices to get a fuller picture of the economy's health.
  • Consumer spending may be a risk. The health of the average consumer is critical for the broader economy. Signs of weakness here could eventually impact the earnings of a wide range of companies, even those not directly in the S&P 10.
Ask about this postAnswers are grounded in this post's content.
Episode Description
Kara and Scott discuss the aftermath of Jimmy Kimmel's highly-rated return, Nvidia’s $100 billion investment in OpenAI, and what Tylenol's parent company should do about the attacks from the Trump administration. Plus, YouTube will reinstate accounts banned for posting misinformation, and a Charlie Kirk poster at Office Depot reignites a fight over whether businesses can refuse service. We’re nominated for a Signal Award! Vote for us here! Watch this episode on the ⁠⁠Pivot YouTube channel⁠⁠. Follow us on Instagram and Threads at ⁠⁠@pivotpodcastofficial⁠⁠. Follow us on Bluesky at ⁠⁠@pivotpod.bsky.social⁠⁠ Follow us on TikTok at ⁠⁠@pivotpodcast⁠⁠. Send us your questions by calling us at 855-51-PIVOT, or email pivot@voxmedia.com Learn more about your ad choices. Visit podcastchoices.com/adchoices
About Pivot
Pivot

Pivot

By New York Magazine

Every Tuesday and Friday, tech journalist Kara Swisher and NYU Professor Scott Galloway offer sharp, unfiltered insights into the biggest stories in tech, business, and politics. They make bold predictions, pick winners and losers, and bicker and banter like no one else. After all, with great power comes great scrutiny. From New York Magazine and the Vox Media Podcast Network.